Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges is a research paper published in Frontiers in Endocrinology (2021). On theSindex it has a DataRank of 0.596. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.596
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIDDK NIH HHS
Grant: R01 DK125285
NIDDK NIH HHS
Grant: P30 DK020541
NIDDK NIH HHS
Grant: R01 DK116873
NIDDK NIH HHS
Grant: R01 DK116904
NIDDK NIH HHS
Grant: R01 DK105015
National Institutes of Health
Grant: 5R01DK116904-02
Novel Selective Type II kinase Inhibitors to treat Diabetes
National Institutes of Health
Grant: 3P60DK020541-33S2
Diabetes Research and Training Center
National Institutes of Health
Grant: 1R01DK116873-01
Epigenetic Control of Human Beta Cell Proliferation
National Institutes of Health
Grant: 5R01DK105015-04
Dyrk Inhibitors for Human Beta Cell Expansion
National Institutes of Health
FWCI
7.53
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals